BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15937913)

  • 1. Barriers to minority participation in breast carcinoma prevention trials.
    Grann VR; Jacobson JS; Troxel AB; Hershman D; Karp J; Myers C; Neugut AI
    Cancer; 2005 Jul; 104(2):374-9. PubMed ID: 15937913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.
    McCaskill-Stevens W; Wilson JW; Cook ED; Edwards CL; Gibson RV; McElwain DL; Figueroa-Moseley CD; Paskett ED; Roberson NL; Wickerham DL; Wolmark N
    Clin Trials; 2013 Apr; 10(2):280-91. PubMed ID: 23335675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast biopsy and race/ethnicity among women without breast cancer.
    Jacobson JS; Grann VR; Hershman D; Troxel AB; Li H; Neugut AI
    Cancer Detect Prev; 2006; 30(2):129-33. PubMed ID: 16621329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
    Gross CP; Filardo G; Mayne ST; Krumholz HM
    Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
    Freedman RA; Virgo KS; He Y; Pavluck AL; Winer EP; Ward EM; Keating NL
    Cancer; 2011 Jan; 117(1):180-9. PubMed ID: 20939011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
    Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
    Freedman AN; Graubard BI; Rao SR; McCaskill-Stevens W; Ballard-Barbash R; Gail MH
    J Natl Cancer Inst; 2003 Apr; 95(7):526-32. PubMed ID: 12671020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to eligibility and enrollment among older women in a clinical trial on osteoporosis: effects of ethnicity and SES.
    Unson CG; Ohannessian C; Kenyon L; Case A; Reisine S; Prestwood K
    J Aging Health; 2004 Jun; 16(3):426-43. PubMed ID: 15155070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.
    Lantz PM; Mujahid M; Schwartz K; Janz NK; Fagerlin A; Salem B; Liu L; Deapen D; Katz SJ
    Am J Public Health; 2006 Dec; 96(12):2173-8. PubMed ID: 17077391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
    Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
    J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers.
    Grette KV; White AL; Awad EK; Scalici JM; Young-Pierce J; Rocconi RP; Jones NL
    Int J Gynecol Cancer; 2021 Nov; 31(11):1403-1407. PubMed ID: 34088749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics.
    Rearden J; Hanlon AL; Ulrich C; Brooks-Carthon M; Sommers M
    Oncol Nurs Forum; 2016 Jan; 43(1):57-66. PubMed ID: 26679445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database.
    Parekh A; Fu W; Hu C; Shen CJ; Alcorn S; Rao AD; Asrari F; Camp MS; Wright JL
    Breast Cancer Res Treat; 2018 Nov; 172(1):201-208. PubMed ID: 30083949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.
    Wang AY; Wong MS; Humbyrd CJ
    Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Race Versus Education and Race Versus Income on Patients' Motivation to Participate in Clinical Trials.
    Kurt A; Kincaid H; Semler L; Jacoby JL; Johnson MB; Careyva BA; Stello B; Friel T; Smulian JC; Knouse MC
    J Racial Ethn Health Disparities; 2018 Oct; 5(5):1042-1051. PubMed ID: 29280106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Wolmark N
    Clin Breast Cancer; 2002 Jun; 3(2):153-9. PubMed ID: 12123540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status.
    Haas JS; Hill DA; Wellman RD; Hubbard RA; Lee CI; Wernli KJ; Stout NK; Tosteson AN; Henderson LM; Alford-Teaster JA; Onega TL
    Cancer; 2016 Feb; 122(4):611-7. PubMed ID: 26709819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity.
    Smith EC; Ziogas A; Anton-Culver H
    JAMA Surg; 2013 Jun; 148(6):516-23. PubMed ID: 23615681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
    Watt GP; John EM; Bandera EV; Malone KE; Lynch CF; Palmer JR; Knight JA; Troester MA; Bernstein JL
    Int J Cancer; 2021 Jun; 148(11):2748-2758. PubMed ID: 33544892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with postpartum use of long-acting reversible contraception.
    Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
    Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.